Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 17032644)

1.

Biochemical and genetic analysis of methylenetetrahydrofolate reductase in Leishmania metabolism and virulence.

Vickers TJ, Orsomando G, de la Garza RD, Scott DA, Kang SO, Hanson AD, Beverley SM.

J Biol Chem. 2006 Dec 15;281(50):38150-8. Epub 2006 Oct 10.

2.
3.

Methylenetetrahydrofolate reductase (MTHFR): a novel target for cancer therapy.

Stankova J, Lawrance AK, Rozen R.

Curr Pharm Des. 2008;14(11):1143-50. Review.

PMID:
18473861
4.
5.

[Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in ischemic vascular disease].

Sánchez-Marín B, Grasa JM.

Rev Neurol. 2006 Nov 16-30;43(10):630-6. Review. Spanish.

6.

C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.

De Mattia E, Toffoli G.

Eur J Cancer. 2009 May;45(8):1333-51. doi: 10.1016/j.ejca.2008.12.004. Epub 2009 Jan 12. Review.

PMID:
19144510
7.

Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania.

Beverley SM, Turco SJ.

Trends Microbiol. 1998 Jan;6(1):35-40. Review.

PMID:
9481823
8.

Phospholipid and sphingolipid metabolism in Leishmania.

Zhang K, Beverley SM.

Mol Biochem Parasitol. 2010 Apr;170(2):55-64. doi: 10.1016/j.molbiopara.2009.12.004. Epub 2009 Dec 23. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk